Open access peer-reviewed chapter

Antioxidant Roles/Functions of Ascorbic Acid (Vitamin C)

Written By

Eunice Agwu, Christian Ezihe and Gyelkur Kaigama

Submitted: 03 December 2022 Reviewed: 17 February 2023 Published: 20 December 2023

DOI: 10.5772/intechopen.110589

From the Edited Volume

Ascorbic Acid - Biochemistry and Functions

Edited by Abdulsamed Kükürt and Volkan Gelen

Chapter metrics overview

301 Chapter Downloads

View Full Metrics

Abstract

Antioxidant plays important roles in cellular function and has been implicated in processes associated with aging, vascular and inflammatory damage, and cancer. Ascorbic acid is a water-soluble essential vitamin with antioxidant properties found in both animals and plants but cannot be synthesized by humans and must be obtained from the diet. Ascorbic acid possessed antioxidant property and readily scavenge reactive oxygen and nitrogen species which are associated with lipid peroxidation, damage of DNA, and proteins. Ascorbic acid as an antioxidant contributes to the maintenance of the vascular system, the reduction of atherogenesis through regulation of collagen synthesis, and the production of prostacyclin and nitric oxide. It reacts with compounds like histamine and peroxides to reduce inflammatory responses. Its antioxidant property is also associated with the reduction of cancer incidences. Ascorbic acid plays a role as a redox cofactor and catalyst in a biological system such as in the conversion of the neurotransmitter dopamine to norepinephrine, in peptide amidation, and in tyrosine metabolism. In the food industry, ascorbic acid is often added to food treated with nitrite in order to reduce the generation of nitrosamines (a carcinogen), found in sausages and cold cuts.

Keywords

  • ascorbic acid
  • mechanism
  • co-antioxidant
  • electron donation
  • cofactor
  • cancer

1. Introduction

Many biological processes in humans and animals such as digestion of food, breathing, drug, and alcohol metabolism, and even the conversion of fats to energy produce free radicals or reactive oxygen species (ROS) which are harmful to the body [1]. If the system cannot cope well, free radicals can lead to a negative chain reaction in the body known as oxidative stress. Oxidative stress is the reflection of an imbalance between the body system’s antioxidants and reactive oxygen species due to a decrease in antioxidants or ROS buildup. Increased ROS production in the body may alter DNA structure, protein, and lipid alteration, the awakening of several stress-induced transcription factors as well as the creation of pro-inflammatory and anti-inflammatory cytokines. [2, 3, 4]. Oxidative stress is shown to be associated with the development of certain disease conditions such as neurodegenerative disease, cardiovascular disease, diabetes, atherosclerosis, hypertension, stroke, heart failure, Parkinson’s disease, and cancer [5, 6, 7]. One solution to this problem is to supplement the diet with antioxidant compounds [8].

Antioxidants are molecules that are capable of reducing or inhibiting the consumption or decomposition of other molecules. Free radicals are produced from oxidative processes, which can trigger several chemical reactions resulting in damage of cells. Antioxidants limit these chemical reactions by clearing or eliminating free radical intermediates and hindering other oxidative reactions by being oxidized themselves [4]. As such, antioxidants are frequently known as deoxidizing agents such as thiols or polyphenols [9]. The body’s antioxidant defense system operates/works by inhibiting the initial production of ROS, scavenge of oxidizing agent, changing oxidizing agent to less-harmful compounds, obstructing the secondary production of harmful metabolites or mediators of inflammation, stopping the circulation of secondary oxidants, restoring the molecular damage generated by ROS, or boosting the endogenous antioxidant defense system of the body.

Ascorbic acid or vitamin C is a water-soluble essential vitamin with antioxidant properties found in both animals and plants but cannot be synthesized by humans and must be obtained from the diet [10]. Ascorbic acid as an antioxidant plays essential function in the prevention of oxidative stress in various tissues in the body [11]. Ascorbic acid can protect several molecules in the body such as carbohydrates, lipids, and nucleic acids (DNA and RNA) from the damaging effects of reactive oxygen species and free radicals that are generated during cellular metabolism as a result of exposure to toxins and pollutants (drugs, cigarettes) or by immune cells [12].

Advertisement

2. Mechanism of action

The mechanism of action of ascorbic acid as an antioxidant is focused on the donation of a hydrogen atom to lipid radicals, removal of molecular oxygen, and quenching of singlet oxygen [13]. Regeneration of α-tocopherol from the tecopheroxyl radical species and aqueous radical scavenging is also the antioxidant mechanism of ascorbic acid [14]. According to [15], ascorbic acid has the ability to bind and reduce transition metal ions especially Fe3+ and Cu2+, and this characteristic contributes to its capacity to promote iron uptake from the diet. The proposed mechanism of action of vitamin C in mammalian cells is shown in Figure 1.

Figure 1.

Proposed mechanism of action of ascorbic acid in mammalian cells.

Advertisement

3. Ascorbic acid as an electron donor

Ascorbic acid is a reducing agent and thus an electron donor. The electron donation ability of ascorbic acid is responsible for its biochemical and physiological roles [14]. The double-bond carbon between the second and third of the 6-carbon molecules of ascorbic acid give two electrons. Ascorbic acid is often referred to as an antioxidant owing to the fact that it prevents other molecules from being consumed by donating electrons [15]. Ascorbic acid as an antioxidant and its interaction with reactive nitrogen species and singlet oxygen has been extensively documented [16]. Ascorbic acid has been utilized as an antioxidant for the stabilization of oxidation-prone medications. These medications include vitamin A, morphine, cholecalciferol, rifampin, promethazine, and sulphacetamide [17].

Electrons from ascorbic acid can react with metals such as copper and iron, leading to the generation of superoxide and hydrogen peroxide, which may later result in the formation of ROS. Consequently, in certain situations, ascorbic acid will give rise to an oxidizing agent by way of its operation as a reducing agent. This reaction occurs in the biological system when different pharmacological doses of ascorbic acid are absorbed in the plasma and extracellular fluid compartment as well as low doses of ascorbic acid in cell culture media containing metals [18].

When vitamin C donates electrons, the electrons are lost sequentially. The product formed after the loss of one electron is a free radical, semidehydroascorbic acid, or ascorbyl radical. When compared with other free radicals, the ascorbyl radical is different because its half-life can be measured in many seconds or even minutes depending on the absence or the presence of oxygen or electron acceptors, especially iron [19]. Ascorbyl radical is relatively stable and fairly reactive. This attribute explains why ascorbic acid may be a preferred antioxidant. In other words, a reactive and a harmful free radical can react with ascorbic acid [20]. The reduction of a reactive free radical with the generation of a less-reactive product is sometimes called free radical scavenging or quenching. Therefore, ascorbic acid is a good free radical scavenger due to its chemical composition [21]. For instance, under some conditions, ascorbyl radical could be estimated in blood and extracellular fluid samples [22].

Upon the loss of second electron, a more stable species, dehydroascorbic acid is formed when compared with ascorbyl free radical. The stability of dehydroascorbic acid depends on temperature and pH of the medium, but is often only in minutes. Dehydroascorbic acid has affinity for facilitated glucose transporters and is transported by a number of them [23]. Variety of oxidants in biological system mediate the formation of both ascorbyl radical and dehydroascorbic acid which includes molecular oxygen, superoxide, hydroxyl radical, hypochlorous acid, reactive nitrogen species, and trace metals like iron and copper. Both dehydroascorbic acid and ascorbyl radical could be reversibly broken down to ascorbic acid via different metabolic pathways and also through oxidizing compounds inside the body system including glutathione [24]. All the ascorbic acids consumed by human beings cannot be regained because there exists just fragmental depletion back to ascorbic acid.

In case of nonreduction of dehydroascorbic acid to ascorbic acid, it will be broken down to 2, 3-diketogulonic acid irreversibly due to the rupture of the lactone ring structure that is a component of ascorbic acid, ascorbyl radical, and dehydroascorbic acid. The 2, 3-diketogulonic acid is metabolized further into other compounds such as xylose, xylonite, lyxonate, and oxalate [25]. The development of oxalate is clinically significant because some persons with hyperoxaluria (excessive oxalate excretion) develop oxalate kidney stones (Figure 2).

Figure 2.

Redox chemistry of vitamin C.

Advertisement

4. Ascorbic acid as a co-antioxidant

Ascorbic acid has been used in combination with other vitamins and compounds to achieve a greater synergistic effect [26]. The synergistic effect of both the vitamins C and E has been reported earlier to prevent the phenomenon of autoxidation [27, 28, 29]. According to Shad et al. [30], ascorbic acid alone has little effect in preventing oxidation of lard oil. It was reported that a combination of ascorbic acid and α-tocopherol provides powerful synergistic antioxidative effect. The above researchers conclude that ascorbic acid role was to protect α-tocopherol from consumption. This characteristic of ascorbic acid is termed as co-antioxidant effect. Barcalay et al. [31] figure that ascorbic acid in sodium dodecyl sulfate (SDS) micelle system provides essential synergistic role in the autoxidation of linoleic acid acting from the aqueous phase to recreate tocopherol in the micellar phase. In a study by Gitto et al. [32], on the antioxidant action of melatonin with tocopherol, ascorbic acid, glutathione, and deferoxamine on homogenates of rat liver revealed combined effects with ascorbic acid and tocopherol. A similar study by Lui et al. [28] illustrated that the collaborative antioxidant effects of lycopene, vitamins E and C, and β-carotene were significantly higher than their antioxidant effects individually. An investigation on the fortification of water-in-extra virgin olive oil emulsion with vitamins by Cuomo et al. [26] showed that the presence of ascorbic acid controls the slowdown of oil oxidation. They also reported that the presence of vitamin C limited the peroxide value variations compared to the olive oil and to emulsions without vitamin fortification. The presence of ascorbic acid obstructs the pro-oxidant effect of α-tocopherol (vitamin E) radical since it could be changed back to α-tocopherol [33] as shown in the reaction below:

TocO+AscHTocOH+Asc.

The mechanism of vitamin E renewal in association with co-antioxidants makes use of greater concentrations of less potent α-tocopherol than lower concentrations. This demonstrates that food containing little amounts of vitamin E with co-antioxidants gives a higher health advantage compared to vitamin E supplements.

Tian et al. [34] observed that co-administration of araloside A and L-ascorbic acid produce coordinated antioxidant activity, and a relationship involving antioxidant cellular indexes with ROS clearing ability was identified. The pretreatment of araloside A and L-ascorbic acid singly or in combination improves both cell sustainability and function of antioxidant enzyme and obstructed the discharge of lactate dehydrogenase (LDH), the agglomeration of Malondialdehyde (MDA), lipid peroxidation (LPO) products, and H2O2; and the manufacturing of intracellular responsive oxygen species (ROS), protein carbonyls and 8-hydroxy-2-deoxy guanosine (8-OHdG).

Advertisement

5. Ascorbic acid as a co-factor of enzymes

Ascorbic acid is an important cofactor in numerous enzymatic reactions such as in the biosynthesis of collagen, neuropeptides, and in the regulation of gene expression. The function of ascorbic acid as a cofactor is also associated with its redox potential. Ascorbic acid aids mixed-function oxidases in the synthesis of several critical biomolecules by maintaining enzyme-bound metals in their reduced forms [12]. These enzymes are either monooxygenases or dioxygenases.

One of these enzymes is dopamine β-hydroxylase (DBH). Ascorbic acid serves as a cofactor for dopamine β-hydroxylase in the conversion of dopamine to norepinephrine through hydroxylation of dopamine in different neuroendocrine tissues synthesizes [35]. Synthesis of catecholamine is ascorbic acid-dependent as ascorbic acid levels are known to be in the millimolar range in the adrenal gland. Ascorbic acid in chromaffin granule is secreted together with catecholamines from chromaffin-cultured cells and in vivo by human adrenal glands, the latter in response to adreno-corticotrophin stimulation [36]. Ascorbic acid can act as a neuromodulator. Its release into the extracellular fluid of the brain, it regulates dopaminergic and glutamatergic transmission. Ascorbic acid is released from glutamatergic neurons as a result of the high-affinity glutamate transporter-exchanging ascorbic acid for glutamate during the glutamate reuptake process [37]. This hetero-exchange process ensures a comparatively high quantity of extracellular ascorbic acid in the forebrain, which may also occur in glial cells [38]. Therefore, it protects nerve cells against glutamate excitotoxicity. As the interaction between ascorbic acid and glutamate is crucial in neuron metabolism, ascorbic acid acts as a metabolic switch that modulates neural metabolism between resting and activation periods [39]. In addition, glutamate from astrocytes in the CNS regulates ascorbic acid release [40]. Several studies have reported the neuroprotective functions of ascorbic acid. Akbari et al. [41] observed that after exposure of rats to radiofrequency waves produced by the BTS mobile antenna, the rats’ brains were preserved from oxidative stress with the help of ascorbic acid. Naseer et al. [42] showed how ascorbic acid can hinder part of the negative impacts of nervous deterioration caused by PTZ in the brain of adult rats. Another related study reported how the neuroprotective activity of ascorbic acid in matured rats may be its ability to decrease the rate of lipid peroxidation and its higher enzymatic effect following seizures and epileptics state caused by pilocarpine [43]. Shokouhi et al. [44] indicated how ascorbic acid possesses a remarkable impact on decreasing the rate of malondialdehyde formation after nerve injury in rats and may have the potential for healing, and the degree of protection does not depend on the dose.

As a cofactor for the enzyme folate reductase, it participates in the conversion of methemoglobin back into hemoglobin and retains folic acid in its reduced form of tetrahydofolic acid, which is necessary for red blood cell maturation. Ascorbic acid stimulates the initial step in cholesterol metabolism to bile acids through the 7-alpha-hydroxylase enzyme. This function may have importance in the creation of gallstones and the maintenance of normal blood cholesterol levels. It is also involved in tyrosine metabolism, carbohydrate metabolism, synthesis of proteins, resistance to infections, and cellular respiration [45].

Ascorbic acid is also an important co-factor for lysyl hydroxylase and prolyl hydroxylase, enzymes essential for collagen biosynthesis, the most abundant extracellular protein. Ascorbic acid is a required element for the fusion of hydroxyproline and hydroxylysine in collagen. Hydroxyproline acts to hold the triple helix of collagen. The absence of hydroxyproline can lead to destabilization of the collagen structure that is not produced at normal rates from the cells. Hydroxylysine is necessary for the process of development of intermolecular crosslinks in collagen. Furthermore, certain carbohydrate remnants are connected to collagen glycosidically via hydroxylysine, an activity that could be essential in the control of crosslink production [46, 47]. Normally, ascorbic acid is considered to control collagen formation via its action on prolyl hydroxylation.

Ascorbic acid supplementation has been found to improve components of the human immune system such as antimicrobial and natural killer cell activities, lymphocyte proliferation, chemotaxis, and delayed-type hypersensitivity. Many cells of the immune system such as phagocytes and t-cells can accumulate ascorbic acid as they are needed to perform their task [48]. Recently, the importance of ascorbic acid in Tet-mediated DNA demethylation has been demonstrated to restrain the growth of acute myeloid leukemia [49], to promote homeostasis of hemopoietic stem cells [50], and to boost the lineage stability of regulatory T (Treg) cells [51]. Thus, ascorbic acid deficiency can result in decreased resistance against certain pathogens, while a higher level enhances several immune system parameters. Ascorbic acid concentrations in the plasma and leukocytes rapidly decline during infections and stress.

Advertisement

6. Ascorbic acid and cancer

Cancer is a broad term that describes the disease that results when cellular changes cause the uncontrolled growth and division of cells [52]. Presently, cancer has been identified as a complicated disorder that involves the modification of gene articulation, supports cell survival and acceleration, and can be altered by genomic and epigenomic components [53]. Genomic components are defined by the modifications at the sites of the genes, aiding mutations, while epigenomic components adapt to changes that do not reverse the chain of DNA bases except their form by histone modification, methylations in DNA bases, and nucleosome alteration [54, 55].

Cancer cells function within an advanced level of oxidative stress, as a result of elevated standard degree of ROS, oncogenic alteration, and metabolic deterioration [56].

Redox imbalance induces cell damage caused by lipid peroxidation generating derangement and loss of function and integrity of the cell membrane, as well as DNA damage, promoting genomic instability and cell proliferation, thereby increasing the somatic mutations and neoplastic transformation [57]. It is estimated that in 2030, the global burden of cancer will be 21.4 million new cases and 13.2 million deaths, mainly due to the growth and aging of the population [58]. The World Health Organization (WHO) states that the consumption of fruits and vegetables can help prevent cancer due to their composition with nutrients such as vitamins, minerals, and fiber [59]. As published in the Dietary Reference Intake (DRI), food containing antioxidants such as ascorbic acid, carotenoids, tocopherol, selenium, and flavonoids are suggested to be consumed because of their antagonistic reaction, as they often have the potential for cancer prevention, suppress degeneration of molecules, and formation of free radicals [60].

The relationship between vitamin C and cancer is still under study and is associated with antioxidant, prooxidant, and gene expression regulator properties [61]. The role of ascorbic acid on tumor advancement relays on whether it is administered orally or intravenously, together with the manifestation and the category of ascorbic acid transporters in the tumor cells. It has been reported that some cancer cells manifest an elevation in the expression of sodium vitamin C transporter 2 (SVCT2) and/or glucose transporter 1 (GLUT1) and absorbs more vitamin C than normal cells for the ascorbic acid transporter’s expression [61]. The high expression of GLUT1 in tumors constitutes the principle of oncological diagnosis based on the positron emission tomography of 18F-fluorodeoxyglucose.

In treatment, ascorbic acid was selectively toxic to cancer cells in vitro and in vivo [62, 63]. In animal models, ascorbic acid either has anti-cancer activity similar to conventional chemotherapy or synergizes with it [64, 65]. Contrarily, there are no data showing that treatment of cancer with ascorbic acid interferes with chemotherapy. Early-phase clinical trials show that i.v. ascorbic acid at 1 g/kg over 90–120 minutes, two to three times weekly is well tolerated and may enhance chemo sensitivity as well as decrease chemotherapy-related side effects [66, 67, 68]. Agathocleous et al. [50] indicated the role of oral ascorbic acid in delaying cancer development in mice which was based on ascorbate-dependent activation of TET and HIF-PHD enzymes. In these mice, oral vitamin C postponed progression of genetically susceptible transplanted hematopoietic cells to acute myelogenous leukemia. In a similar study in lymphoma xenograft mode, tumor development was decreased by oral vitamin C, which had HIF-1-dependent anti tumorigenic properties [69]. Treatment of cancer to reduce tumor growth in many rodent models was mediated by parenteral ascorbic acid to produce treatment concentrations [62, 65, 70, 71, 72].

Ascorbic acid concentrations in cancer patients are often at deficiency concentrations [73, 74], the basis for which is still unknown. The justification for the above may include generalized cancer wasting, improved consumption of vitamins by cancer cells, or suppression of vitamin C carriers. It is consequently, in accordance to determine whether there is a place for vitamin C as a treatment regimen through rectification of vitamin C deficiency, irrespective of parenteral administration. The outcome of sporadic treatment trials in persons with advanced stages of cancers particularly colon and rectal cancers were negative [75]. Based on recent in vitro evidence, correction of ascorbate deficiency may aid conventional hypomethylating agents, that is, DNA methyltransferase inhibitors, to exert maximal effect [74]. The rationale for the use of high-dose i.v. ascorbate in cancer treatment is not to correct plasma deficiency, but rather to induce an oxidative stress on cancer cells [62] and to ensure adequate delivery of ascorbic acid within tumors for optimal cofactor function [76]. It is therefore important to accept that only parenteral ascorbic acid has yielded results for treatment success in the early phase of human trials in the literature. The use of rodent models in confirmed cancer cases, only parenteral ascorbic acid has proven to be beneficial irrespective of the model. This information gives directions for clinical trials [77].

Advertisement

7. Conclusion

Ascorbic acid is widely regarded as an essential antioxidant in both humans and animals. As an antioxidant, it has two basic functions: first, it reacts and inactivates free radicals in plasma, cytosol, and extracellular fluid compartment of the body. Second, it can regenerate vitamin E in its oxidized form. Those functions are possible because of its ability to donate electron. Studies have reported the use of ascorbic acid in the prevention and treatment of cancer. There are different publications on the antioxidant activity of ascorbic acid through various mechanisms at different dosages such as reduction of cytotoxicity, decreased apoptosis, and preservation of tumor cells from lipid peroxidation, inhibiting cancer cell growth, and secretion of inflammatory cytokines. The briefly discussed antioxidant role of ascorbic acid just represents some abilities of its involvement in physiological activities. More research is needed to understand dose–response variations, as well as its targeting mechanisms of action as an antioxidant and anticancer agent, to aid in the prevention and treatment of cancer, with the goal of improving the quality of life for both patients and the general population.

Advertisement

Acknowledgments

We thank the management of the Federal College of Animal Health and Production Technology, Vom, and Mr. Kenneth Emeribe for his encouragement during the course of this work.

Advertisement

Conflict of interest

The authors declare no conflict of interest.

References

  1. 1. Kurutas EB. The importance of antioxidants which play the role in cellular response against oxidative/nitrosative stress: Current state. Nutrition Journal. 2015;15:71
  2. 2. Esra B, Umit MS, Cansin S, Serpil E, Omer K. Oxidative stress and antioxidant defense. World Allergy Organisation Journal. 2012;5(1):9-19
  3. 3. Ayala A, Munoz MF, Arguelles S. Lipid peroxidation: Production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2- nonenal. Oxidative Medicine and Cellular Longevity. 2014;2014:360-438
  4. 4. Liang X, Wang S, Wang L, Ceylan AF, Ren J, Zhang Y. Mitophagy inhibitor liensinine suppresses doxorubicin-induced cardiotoxicity through inhibition of drp1-mediated maladaptive mitochondrial fission. Pharmacology Research. 2020;157:104846
  5. 5. Halliwell B. Oxidative stress and neurodegeneration: Where are we now? Journal of Neurochemistry. 2007;97:1634-1656
  6. 6. Moore SP, Kruchten J, Toomire KJ, Strauss PR. Transcription factors and DNA repair enzymes compete for damaged promoter sites. The Journal of Biological Chemistry. 2016;291:5452-5460
  7. 7. Aminjan H, Abtahi SR, Hazrati E, Chamanara M, Jalili PB. Targeting of oxidative stress and inflammation through ROS/NFkappaB pathway in phosphine-induced hepatotoxicity mitigation. Life Science. 2019;232:116607
  8. 8. Krishnaiah D, Sarbatly R, Nithyanandam R. A review of the antioxidant potential of medicinal plant species. Journal of Food and Bioproducts processing. 2011;89(3):217-233
  9. 9. Duarte TL, Lunec J. When is an antioxidant not an antioxidant? A review of novel actions and reactions of vitamin C. Free Radical Research. 2005;39(7):671-686
  10. 10. Linster CL, Van Schaftingen E. Vitamin C: Biosynthesis, recycling and degradation in mammals. The FEBS Journal. 2007;274(1):1-22
  11. 11. Jelodar G, Nazifi S, Akbari A. The prophylactic effect of vitamin C on induced oxidative stress in rat testis following exposure to 900 MHz radio frequency wave generated by a BTS antenna model. Electromagnetic and Biological Medicine. 2013;32(3):409-416
  12. 12. Levine M, Padayatty SJ. Vitamin C. In: Ross AC, Caballero B, Cousins RJ, Tucker KL, Ziegler TR, editors. Modern Nutrition in Health and Disease. 11th ed. Baltimore, MD: Lippincott Williams & Wilkins; 2014. pp. 416-426
  13. 13. Du J, Cullen JJ, Buettner GR. Ascorbic acid: Chemistry, biology and treatment of cancer. Journal of Biochemistry and Biophysics. 1826;2012:443-457. DOI: 10.1016/j.bbcan.2012.06.003
  14. 14. Padayatty SJ, Katz A, Wang Y, Eck P, Kwon O, Lee JH, et al. Vitamin C as an antioxidant: Evaluation of its role in disease prevention. Journal of the American College of Nutrition. 2003;22:18-35
  15. 15. Padayatty SJ, Levine M. Vitamin C Physiology. The known and the unknown and goldilocks. Oral Diseases. 2016;22(6):463-493
  16. 16. Sinko PJ. Chemical Kinetics and Stability, Martin’s Physical Pharmacy and Pharmaceutical Sciences. 5th ed. Baltimore: Lippincott Williams & Wilkins; 2006
  17. 17. Moribe K, Limwikrant W, Higashi K, Yamamoto K. Drug nanoparticle formulation using ascorbic acid derivatives. Journal of Drug Delivery. 2011;2011:138929. DOI: 10.1155/2011/138929
  18. 18. Parrow NL, Leshin JA, Levine M. Parenteral ascorbate as a cancer therapeutic: A reassessment based on pharmacokinetics. Antioxidants & Redox Signaling. 2013;19:2141-2156
  19. 19. Buettner GR. The pecking order of free radicals and antioxidants: Lipid peroxidation, alpha-tocopherol, and ascorbate. Archives of Biochemistry and Biophysics. 1993;300:535-543
  20. 20. Buettner GR, Moseley PL. EPR spin trapping of free radicals produced by bleomycin and ascorbate. Free Radical Research Communications. 1993;19:S89-S93
  21. 21. Bielski BHJ. Chemistry of ascorbic acid radicals. In: Seib PA, Tolbert BM, editors. Ascorbic Acid: Chemistry, Metabolism, and Uses. Washington DC: American Chemical Society; 1982. pp. 81-100
  22. 22. Chen Q , Espey MG, Sun AY, Lee JH, Krishna MC, Shacter E, et al. Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivo. Proceedings of National Academic Science, U S A. 2007;104:8749-8754
  23. 23. Corpe CP, Eck P, Wang J, Al-Hasani H, Levine M. Intestinal dehydroascorbic acid (DHA) transport mediated by the facilitative sugar transporters, GLUT2 and GLUT8. The Journal of Biological Chemistry. 2013;288:9092-9101
  24. 24. Rumsey SC, Daruwala R, Al-Hasani H, Zarnowski MJ, Simpson IA, Levine M. Dehydroascorbic acid transport by GLUT4 xenopus oocytes and isolated rat adipocytes. The Journal of Biological Chemistry. 2000;275:28246-28253
  25. 25. Nishikimi M, Yagi K. Biochemistry and molecular biology of ascorbic acid biosynthesis. Subcellular Biochemistry. 1996;25:17-39
  26. 26. Cuomo F, Vinelli G, Chirascu C, Moreoni E, Lopez F. Antioxidant effect of vitamins in olive oil emulsion. Colloids and Interfaces. 2020;4(23):1-12
  27. 27. Niki E, Kawarami A, Yammamoto Y, Kamiya Y. Oxidation of lipids VIII. Synergistic inhibition of oxidation of phosphatidylcholine liposomes in acqueous dispersions by Vitamin E and Vitamin C. Bulletin of the Chemical Society of Japan. 1985;58:1971-1975
  28. 28. Liu D, Shi J, Colina Ibarra A, Kakuda Y, Jun XS. The scavenging capacity and synergistic effects of lycopene, vitamin E, vitamin C, and β-carotene mixtures on the DPPH free radical. LWT- Food Science and Technology. 2008;41:1344-1349
  29. 29. Dai F, Chen WF, Zhou B. Antioxidant synergism of green tea polyphenols with α-tocopherol and l-ascorbic acid in SDS micelles. Biochimie. 2008;90:1499-1505
  30. 30. Shad Z, Arsalon A, Bano R, Khan MF, Ahmed I. Physiocochemical, biochemical and antioxidant properties of ascorbic acid. Baqai Journal of Health Science. 2011;14(2):33-40
  31. 31. Barclay LR, Locke SJ, Macneil JM. Autoxidation in micelles. Synergism of vitamin C with lipid-soluble vitamin E and water-soluble Trolox. Canadian Journal of Chemistry. 1985;63:366-374
  32. 32. Gitto E, Tan DX, Reiter RJ, Karbownik M, Manchester LC, Cuzzocrea S, et al. Individual and synergistic antioxidative actions of melatonin: Studies with vitamin E, vitamin C, glutathione and desferrrioxamine (desferoxamine) in rat liver homogenates. The Journal of Pharmacy and Pharmacology. 2001;53:1393-1401
  33. 33. Rietjens IMCM, Boersma MG, Haan LD, Spenkelink B, Awad HM, Cnubben NHP, et al. The pro-oxidant chemistry of the natural antioxidants vitamin C, vitamin E, carotenoids and flavonoids. Environmental Toxicology and Pharmacology. 2002;11:321-333
  34. 34. Tian Y, Zhang X, Du M, Li F, Xiao M, Zhang W. Synergistic antioxidant effects of araloside A and L- ascorbic acid on H2O2-induced HEK 293 cells: Regulation of cellular antioxidant status. Oxidative Medicine and Cellular Longivity. 2021;2021:1-20
  35. 35. Levine M. Ascorbic acid specifically enhances dopamine beta-monooxygenase activity in resting and stimulated chromaffin cells. The Journal of Biological Chemistry. 1986;261(16):7347-7356
  36. 36. Padayatty SJ, Doppman JL, Chang R, Wang Y, Gill J, Papanicolaou DA, et al. Human adrenal glands secrete vitamin C in response to adrenocorticotrophic hormone. The American Journal of Clinical Nutrition. 2007;86(1):145-149
  37. 37. Rebec GV, Pierce RC. A vitamin as neuromodulator: Ascorbate release into the extracellular fluid of the brain regulates dopaminergic and glutamatergic transmission. Progress in Neurobiology. 1994;43(6):537-565
  38. 38. Acuna AI, Esparza M, Kramm C, Beltran FA, Parra AV, Cepeda C, et al. A failure in energy metabolism and antioxidant uptake precede symptoms of Huntington's disease in mice. Nature Communications. 2013;4:2917
  39. 39. Harrison FE, May JM. Vitamin C function in the brain: Vital role of the ascorbate transporter SVCT2. Free Radical Biology & Medicine. 2009;46(6):719-730
  40. 40. Castro MA, Beltran FA, Brauchi S, Concha I. A metabolic switch in brain: Glucose and lactate metabolism modulation by ascorbic acid. Journal of Neurochemistry. 2009;110(2):423-440
  41. 41. Akbari A, Jelodar G, Nazifi S. Vitamin C protects rat cerebellum and encephalon from oxidative stress following exposure to radiofrequency wave generated by a BTS antenna model. Toxicology Mechanisms and Methods. 2014;24(5):347-352
  42. 42. Naseer MI, Ullah I, Ullah N, Lee HY, Cheon EW, Chung J, et al. Neuroprotective effect of vitamin C against PTZ induced apoptotic neurodegeneration in adult rat brain. Pakistan Journal of Pharmaceutical Sciences. 2011;24(3):263-268
  43. 43. Santos LF, Freitas RL, Xavier SM, Saldanha GB, Freitas RM. Neuroprotective actions of vitamin C related to decreased lipid peroxidation and increased catalase activity in adult rats after pilocarpine-induced seizures. Pharmacology, Biochemistry, and Behavior. 2008;89(1):1-5
  44. 44. Shokouhi G, Hadidchi S, Ghorbanihaghjo A, Rahbani-Noubar M, Panahi S, Forouzanfar M, et al. Neuroprotective effect of ascorbic acid in experimental blunt sciatic nerve injury in rats. Internet Journal of Nutritional Wellness. 2005;1(2)
  45. 45. Carr AC, Maggini S. Vitamin C and immune function. Nutrients. 2017;9(11):1211
  46. 46. Darr D, Combs S, Pinnell S. Ascorbic acid and collagen synthesis: Rethinking a role for lipid peroxidation. Archives of Biochemistry and Biophysics. 1993;307(2):331-335
  47. 47. Dembure PP, Janko AR, Priest JH, Elsas LJ. Ascorbate regulation of collagen biosynthesis in Ehlers-Danlos syndrome, type VI. Metabolism. 1987;36(7):687-691
  48. 48. Wintergerst ES, Maggini S, Hornig DH. Immune-enhancing role of vitamin C and zinc and effect on clinical conditions. Annals of Nutrition & Metabolism. 2006;50(2):85-94
  49. 49. Cimmino L, Dolgalev I, Wang Y, Yoshimi A, Martin GH, Wang J, et al. Restoration of TET2 function blocks aberrant self-renewal and leukemia progression. Cell. 2017;170:1079-1095
  50. 50. Agathocleous M, Meacham CE, Burgess RJ, Piskounova E, Zhao Z, Crane GM, et al. Ascorbate regulates haematopoietic stem cell function and leukaemogenesis. Nature. 2017;549:476-481
  51. 51. Yue X, Trifari S, Aijo T, Tsagaratou A, Pastor WA, et al. Control of Foxp3 stability through modulation of TET activity. The Journal of Experimental Medicine. 2016;213:377-397
  52. 52. Villagran M, Ferreira J, Martorell M, Mardones L. The role of vitamin C in cancer prevention and therapy: A literature review. Antioxidants. 2021;10:1894. DOI: 10.3390/antiox10121894
  53. 53. Sung B, Prasad S, Yadav VR, Lavasanifar A, Aggarwal BB. Cancer and diet: How are they related? Free Radical Research. 2011;45(8):864-879
  54. 54. Greenman C, Stephens P, Smith R, Dalgliesh GL, Hunter C, Bignell G, et al. Patterns of somatic mutation in human cancer genomes. Nature. 2007;446(7132):153-158
  55. 55. Costa FF. Epigenomics in cancer management. Cancer Management and Research. 2010;2:255-265
  56. 56. Akladios FN, Andrew SD, Parkinson CJ. Selective induction of oxidative stress in cancer cells via synergistic combinations of agents targeting redox homeostasis. Bioorganic & Medicinal Chemistry. 2015;23(13):3097-3104
  57. 57. Rajakumar T, Pugalendhi P, Thilagavathi S. Dose response chemopreventive potential of allyl isothiocyanate against 7, 12-dimethylbenz(a)anthracene induced mammary carcinogenesis in female Sprague-Dawley rats. Chemico-Biological Interactions. 2015;231:35-43
  58. 58. INCA. Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA). Incidência de Câncer no Brasil. Estimativa. 2014. Available from: http://www. inca.gov.br/estimativa/2014/estimativa-24042014.pdf.
  59. 59. Xiao H, Liang H, Wang JB, Huang CY, Wei WQ , Boniol M, et al. Attributable causes of cancer in China: Fruit and vegetable. Chinese Journal of Cancer Research. 2011;23(3):171-176
  60. 60. INCA. Instituto Nacional de Câncer José Alencar Gomes Silva (INCA). Consenso Nacional de Nutrição Oncológica. v. 2; 2011. Available from: http://www1.inca.gov.br/inca/Arquivos/consenso_nutricao_vol2.pdf
  61. 61. Vissers MCM, Das AB. Potential mechanisms of action for vitamin C in cancer: Reviewing the evidence. Frontiers in Physiology. 2018;9:809. DOI: 10.3389/fphys.2018.00809
  62. 62. Chen Q , Espey MG, Sun AY, Pooput C, Kirk KL, Krishna MC, et al. Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice. Proceeding of National Academic Science, USA. 2008;105:11105-11109
  63. 63. Verrax J, Calderon PB. Pharmacologic concentrations of ascorbate are achieved by parenteral administration and exhibit antitumoral effects. Free Radical Biology & Medicine. 2009;47:32-40
  64. 64. Serrano OK, Parrow NL, Violet PC, Yang J, Zornjak J, Basseville A, et al. Antitumor effect of pharmacologic ascorbate in the B16 murine melanoma model. Free Radical Biology & Medicine. 2015;87:193-203
  65. 65. Xia J, Xu H, Zhang X, Allamargot C, Coleman KL, Nessler R, et al. Multiple myeloma tumor cells are selectively killed by pharmacologically-dosed ascorbic acid. eBioMedicine. 2017;18:41-49
  66. 66. Carr AC, Vissers MC, Cook JS. The effect of intravenous vitamin C on cancer- and chemotherapy-related fatigue and quality of life. Frontiers in Oncology. 2014;4:283
  67. 67. Hoffer LJ, Robitaille L, Zakarian R, Melnychuk D, Kavan P, Agulnik J, et al. High-dose intravenous vitamin C combined with cytotoxic chemotherapy in patients with advanced cancer: A phase I-II clinical trial. PLoS One. 2015;10:e0120228
  68. 68. Schoenfeld JD, Sibenaller ZA, Mapuskar KA, Wagner BA, Cramer-Morales KL, Furqan M, et al. O2- and H2O2-mediated disruption of Fe metabolism causes the differential susceptibility of NSCLC and GBM cancer cells to pharmacological ascorbate. Cancer Cell. 2017;31:487-500
  69. 69. Gao P, Zhang H, Dinavahi R, Li F, Xiang Y, Raman V, et al. HIF-dependent antitumorigenic effect of antioxidants in vivo. Cancer Cell. 2007;12:230-238
  70. 70. Espey MG, Chen P, Chalmers B, Drisko J, Sun AY, Levine M, et al. Pharmacologic ascorbate synergizes with gemcitabine in preclinical models of pancreatic cancer. Free Radical Biology & Medicine. 2011;50:1610-1619
  71. 71. Ma Y, Chapman J, Levine M, Polireddy K, Drisko J, Chen Q. High-dose parenteral ascorbate enhanced chemosensitivity of ovarian cancer and reduced toxicity of chemotherapy. Science Translational Medicine. 2014, 2014;6:222ra218
  72. 72. Rouleau L, Antony AN, Bisetto S, Newberg A, Doria C, Levine M, et al. Synergistic effects of ascorbate and sorafenib in hepatocellular carcinoma: New insights into ascorbate cytotoxicity. Free Radical Biology & Medicine. 2016;95:308-322
  73. 73. Huijskens MJ, Wodzig WK, Walczak M, Germeraad WT, Bos GM. Ascorbic acid serum levels are reduced in patients with hematological malignancies. Results in Immunology. 2016;6:8-10
  74. 74. Liu M, Ohtani H, Zhou W, Orskov AD, Charlet J, Zhang YW, et al. Vitamin C increases viral mimicry induced by 5-aza-20-deoxycytidine. Proceedings of National Academic Science, USA. 2016;113:10238-10244
  75. 75. Moertel CG, Fleming TR, Creagan ET, Rubin J, O’Connell MJ, Ames MM. High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison. The New England Journal of Medicine. 1985;312:137-141
  76. 76. Kuiper C, Vissers MC, Hicks KO. Pharmacokinetic modeling of ascorbate diffusion through normal and tumor tissue. Free Radical and Biological Medicine. 2014;77:340-352
  77. 77. Shenoy N, Bhagat T, Nieves E, Stenson M, Lawson J, Choudhary GS, et al. Upregulation of TET activity with ascorbic acid induces epigenetic modulation of lymphoma cells. Blood Cancer Journal. 2017;7:587

Written By

Eunice Agwu, Christian Ezihe and Gyelkur Kaigama

Submitted: 03 December 2022 Reviewed: 17 February 2023 Published: 20 December 2023